Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT

MLA

François Jamar, et al. Imaging of Treatment Response and Minimal Residual Disease in Multiple Myeloma: State of the Art WB-MRI and PET/CT. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....456a35feae8e505295e9f3ca61464ab8&authtype=sso&custid=ns315887.

APA

François Jamar, Bruno Vande Berg, Frédéric Lecouvet, Souad Acid, Marie-Christiane Vekemans, Jens Hillengass, Jacques Malghem, Koenraad Verstraete, Joris Wuts, Olivier Gheysens, Thomas Van Den Berghe, Thomas Kirchgesner, & Vincent Vandecaveye. (2022). Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT.

Chicago

François Jamar, Bruno Vande Berg, Frédéric Lecouvet, Souad Acid, Marie-Christiane Vekemans, Jens Hillengass, Jacques Malghem, et al. 2022. “Imaging of Treatment Response and Minimal Residual Disease in Multiple Myeloma: State of the Art WB-MRI and PET/CT,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....456a35feae8e505295e9f3ca61464ab8&authtype=sso&custid=ns315887.